The N-myristoyltransferases, NMT1 and NMT2, catalyse addition of the fatty acid myristate to the N-terminal glycine residues of substrate proteins. This post-translational modification is required for the subcellular targeting, protein conformation and biological activity of many signal transduction proteins.

1. Brand S, Wyatt P, Thompson S, Smith V, Bayliss T, Harrison J, Norcross N, Cleghrn L, Gilbert I, Brenk R. (2015) N-myristoyl transferase inhibitors. Patent number: US9156811B2. Assignee: University of Dundee. Priority date: 29/08/2009. Publication date: 13/10/2015.

2. Carr R, Solari R, Bell AS, Tate EW, Bonnert R. (2024) Cytotoxic imidazo[1,2-a]pyridine compounds and their use in therapy. Patent number: WO2024052685A1. Assignee: MyricX Pharma Limited, Imperial College Innovations Limited. Priority date: 14/04/2023. Publication date: 14/03/2024.